logo

NGN-PET

…

  • HOME
  • NGN-PET
    • Research Project
    • Objectives
    • Workpackages structure
    • Funding
    • WP1
    • WP2
    • WP3
    • WP4
    • WP5
    • WP6
  • IMI_JU
  • PARTNERS
    • NMI
    • L&B
    • KCL
    • GRÜNENTHAL
    • AXXAM
    • ESTEVE
  • NEWS
    • NEWS
  • LINKS

How the NGN-PET logo was made

https://ngn-pet.com/wp-content/uploads/2020/05/How-the-logo-was-made.mp4
How the NGN-PET logo was made
Tweet
Xavier Codony September 27, 2017May 27, 2020 news No Comments
  • ← Axxam coordinates European research project on chronic pain for innovative medicines
  • Second biannual meeting of the NGN-PET project →

Leave a Reply

Your email address will not be published. Required fields are marked *

CellStemCell

Tweets by CellStemCell

IASP

Tweets by IASPnetwork

EFIC

Tweets by EFIC_org

IMI

Tweets by IMI_JU

NGN-PET is supported by over € 3.3 million funding from the Innovative Medicines Initiative 2 Joint Undertaking, under grant agreement No 116072. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA Companies. The project duration is 3 years.

Contact Information

  • Project Office/General Enquires
  • Project Leader: Xavier Codony , ESTEVE.
  • Project Coordinator: Dr. Paola Tarroni, Axxam SpA.
Copyright © 2023 NGN-PET - Legal notice. - Cookies policy.